Morris Daily Herald


Friend's E-mail:
  (maximum of 3 addresses separated by commas)
Your E-mail:
A Brief Comment (150 char max / 25 word max)
Article:

FDA speedily approves Imbruvica, a treatment for rare lymphoma

(MCT) — Less than five months after a pair of biotech companies submitted a candidate cancer drug to the Food & Drug Administration, the FDA has approved the drug ibrutinib as a "breakthrough therapy" for a rare and deadly form of the cancer, mantle cell lymphoma.

Security image:   
Note:the e-mail sent will contain information, such as your IP address (54.81.82.225), for purposes of tracking abuse. Use of this software to spam or harass individuals can and may result in penalties punishable by law.

[x] Close Window

Copyright © 2014 Morris Daily Herald. All rights reserved.